Brief: Eledon Pharmaceuticals Receives FDA Clearance Of IND Application To Evaluate Tegoprubart In IGA Nephropathy
06/09/2022 22:12
Sept 6 (Reuters) - Eledon Pharmaceuticals Inc ELDN.O :
* ELEDON PHARMACEUTICALS RECEIVES FDA CLEARANCE OF IND
APPLICATION
TO EVALUATE TEGOPRUBART IN IGA NEPHROPATHY
Source text for Eikon: ID:nGNX9byWg1
Further company coverage: ELDN.O
Recent news on Eledon Pharmaceuticals
See all newsBrief: Eledon Presents Updated Long-Term Phase 2 Bestow Extension Study Results At The International Congress Of The Transplantation Society
Eledon Pharmaceuticals Inc reports results for the quarter ended June 30 - Earnings Summary
Eledon Pharmaceuticals Q2 net loss widens on warrant liability changes
Eledon Pharmaceuticals Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Natera And Eledon Announce Strategic Partnership For Prospera™ Monitoring In Planned Phase 3 Kidney Transplant Trial